Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.63
-0.05 (-0.75%)
Apr 7, 2026, 4:00 PM EDT - Market closed
Aura Biosciences Employees
Aura Biosciences had 113 employees as of December 31, 2025. The number of employees increased by 4 or 3.67% compared to the previous year.
Employees
113
Change (1Y)
4
Growth (1Y)
3.67%
Revenue / Employee
n/a
Profits / Employee
-$939,743
Market Cap
425.32M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 113 | 4 | 3.67% | 113 | 0 |
| Dec 31, 2024 | 109 | 20 | 22.47% | 106 | 3 |
| Dec 31, 2023 | 89 | 17 | 23.61% | 88 | 1 |
| Dec 31, 2022 | 72 | 20 | 38.46% | 70 | 2 |
| Dec 31, 2021 | 52 | - | - | 52 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Ginkgo Bioworks Holdings | 485 |
| REGENXBIO | 371 |
| Sutro Biopharma | 137 |
| Nautilus Biotechnology | 130 |
| enGene Holdings | 82 |
| Lexeo Therapeutics | 59 |
| Altimmune | 57 |
AURA News
- 9 days ago - Aura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights - GlobeNewsWire
- 4 months ago - Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 5 months ago - Aura Biosciences Reports Third Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 7 months ago - Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 8 months ago - Aura Biosciences Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 11 months ago - Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants - GlobeNewsWire
- 11 months ago - Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants - GlobeNewsWire
- 11 months ago - Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire